You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ven

Showing 1 - 25 of 275
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Leukemia Trial in Shanghai (CALGE-VEN- RIC-MBF)

Recruiting
  • Refractory Leukemia
  • CALGE-VEN- RIC-MBF
  • Shanghai, Shanghai, China
  • +2 more
May 22, 2023

Allogeneic Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia Trial in Suzhou (VEN+AZA+Modified BUCY)

Recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Acute Lymphoblastic Leukemia
  • VEN+AZA+Modified BUCY
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Apr 10, 2023

Multiple Myeloma Trial in Rochester (procedure, biological, drug)

Not yet recruiting
  • Multiple Myeloma
  • Biospecimen Collection
  • +12 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Sep 15, 2023

Elderly AML Patients, Unfit, New-diagnosis AML, Acute Myeloid Leukemia Trial in Kunming (Experimental: Venetoclax in combination

Not yet recruiting
  • Elderly AML Patients
  • +4 more
  • Experimental: Venetoclax in combination with Decitabine (+-sorafenib)
  • Active Comparator: Standard dose of Venetoclax + Azacitidine
  • Kunming, Yunnan, China
    The Second Affiliated Hospital of Kunming Medical University.
Oct 3, 2023

Acute Myeloid Leukemia Trial in Marseille, Nice (Pharmacokinetic sampling, Vital status determination, Toxicity assessments)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Pharmacokinetic sampling
  • +3 more
  • Marseille, France
  • +1 more
Sep 6, 2023

High Risk CLL, Chronic Lymphocytic Leukemia Trial (VenObi+Ven or VenObi+VenZan)

Not yet recruiting
  • High Risk CLL
  • Chronic Lymphocytic Leukemia
  • VenObi+Ven or VenObi+VenZan
  • (no location specified)
Jul 26, 2022

Acute Myeloid Leukemia Trial in Beijing (Ven+CAG)

Recruiting
  • Acute Myeloid Leukemia
  • Beijing, Beijing, China
    Peking University People's Hospital
Jun 23, 2023

Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Suzhou

Recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +2 more
  • VEN+AZA+Modified BUCY
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Apr 10, 2023

Venetoclax Combined With Azacitidine Plus Homoharringtonine, Venetoclax Combined With Azacitidine Trial in Guangzhou (VEN

Recruiting
  • Venetoclax Combined With Azacitidine Plus Homoharringtonine
  • Venetoclax Combined With Azacitidine
  • VEN combined with azacitidine plus homoharringtonine
  • VEN combined with azacitidine
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Jul 9, 2022

Acute Myeloid Leukemia Trial in Suzhou (Venetoclax, Homoharringtonine, Cytarabine)

Recruiting
  • Acute Myeloid Leukemia
  • Suzhou, Jiangsu, China
    Qiu Huiying
Mar 28, 2023

Relapsed or Refractory Hematologic Malignancies Trial in Chicago (Omacetaxine, Venetoclax)

Recruiting
  • Relapsed or Refractory Hematologic Malignancies
  • Chicago, Illinois
    University of Illinois Cancer Center
Sep 27, 2022

Molecular Abnormalities on Response of VAH vs. VEN+HMA in RR-AML

Completed
  • Relapsed Acute Myeloid Leukemia
  • +3 more
  • VAH regimen
  • VEN+HMA regimen
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Jul 8, 2022

Acute Myeloid Leukemia (AML) Trial in Leipzig (VEN+AZA-5)

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • Leipzig, Germany
    Universitätsklinikum Leipzig, Klinik und Poliklinik für Hämatolo
Apr 25, 2023

Refractory Acute Myeloid Leukemia Trial in Shanghai (Aza-Ven-allo-HSCT)

Recruiting
  • Refractory Acute Myeloid Leukemia
  • Shanghai, China
  • +2 more
May 27, 2021

Cancer Trial (Pneupac VR1)

Withdrawn
  • Cancer
  • Pneupac VR1
  • (no location specified)
Mar 10, 2022

Acute Myeloid Leukemia Trial in Italy (Venetoclax and Decitabine)

Recruiting
  • Acute Myeloid Leukemia
  • Venetoclax and Decitabine
  • San Giovanni Rotondo, Foggia, Italy
  • +24 more
Aug 8, 2022

Acute Myeloid Leukemia Trial in Beijing (Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte

Recruiting
  • Acute Myeloid Leukemia
  • Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
  • "3+7"
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Sep 29, 2023

Relapsed/Refractory Acute Myeloid Leukemia Trial in Beijing

Recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia
  • Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
  • Best-Available Therapy(BAT) Regimen
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Oct 10, 2023

Chronic Myeloid Leukemia Trial in France (Venetoclax)

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Amiens, France
  • +14 more
Mar 3, 2023

Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

Recruiting
  • Recurrent Chronic Lymphocytic Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 17, 2022

Mantle Cell Lymphoma, Lymphoma Trial in United States (BR-I (bendamustine, rituximab, ibrutinib), VEN (Venetoclax))

Active, not recruiting
  • Mantle Cell Lymphoma
  • Lymphoma
  • BR-I (bendamustine, rituximab, ibrutinib)
  • VEN (Venetoclax)
  • Basking Ridge, New Jersey
  • +6 more
Feb 3, 2022

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Worldwide (JNJ-74856665, AZA, VEN)

Active, not recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Birmingham, Alabama
  • +22 more
Jan 27, 2023

Primary Varicose Veins Trial (Ven Restoration Therapy)

Unknown status
  • Primary Varicose Veins
  • Ven Restoration Therapy
  • (no location specified)
Sep 1, 2020

Leukemia, Myeloid, Acute Trial in Worldwide (JNJ-75276617, Venetoclax (VEN), Azacitidine (AZA))

Recruiting
  • Leukemia, Myeloid, Acute
  • Birmingham, Alabama
  • +30 more
Aug 11, 2022

Acute Myeloid Leukemia Trial in Tianjin (Different induction chemo regimens)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Different induction chemotherapy regimens
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Sep 27, 2023